[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"complicated-appendicitis\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:complicated-appendicitis":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,42,73],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":4,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":30,"lastUpdatePostDateStruct":31,"startDateStruct":34,"completionDateStruct":36,"leadSponsor":38,"locationsCount":41},"100639650","oral-lactulose-for-gastrointestinal-recovery-after-complex-appendectomy-100639650",false,"NCT07589465","Oral Lactulose for Gastrointestinal Recovery After Complex Appendectomy","Oral Lactulose for Postoperative Gastrointestinal Recovery After Complex Appendectomy: A Prospective Triple-Blind Placebo-Controlled Single-Center Randomized Trial","Inclusion Criteria:\n\n* 1.Age ≥18 years.2.Complicated appendicitis confirmed by SAS2.0 score, intraoperative findings, or pathology.3.Undergoing appendectomy (open or laparoscopic).4.Able to provide informed consent and comply with follow-up.\n\nExclusion Criteria:\n\n* 1.Preoperative intestinal obstruction, IBD, or intestinal tumor.2.Planned postoperative fasting \\>48 hours.3.Hypersensitivity to lactulose or placebo.4.Severe organ dysfunction (ASA ≥IV).5.Pregnancy or lactation.6.Cognitive or psychiatric disorder impairing follow-up.","ALL","18 Years",{"count":19,"type":20},150,"ESTIMATED","INTERVENTIONAL",[23],"NA","This is a prospective, triple-blind, placebo-controlled, single-center randomized clinical trial to evaluate the efficacy and safety of early oral lactulose for promoting postoperative gastrointestinal functional recovery in patients undergoing appendectomy for complicated appendicitis. Eligible patients aged ≥18 years with complicated appendicitis confirmed by preoperative SAS 2.0 score, intraoperative findings, or postoperative pathology will be randomly assigned 1:1 to receive oral lactulose or placebo on postoperative day 1 and day 2. The primary outcome is time to GI-2 (time from surgery to the later of first defecation or first tolerance of solid food). Secondary outcomes include time to first flatus, defecation rate within 72 hours, postoperative nausea and vomiting, length of hospital stay, medical costs, postoperative complications, and lactulose-related adverse events. A total of 150 patients will be enrolled. This study aims to provide high-level evidence for optimizing postoperative management in patients with complicated appendicitis.",[26,27,28],"Ileus Postoperative","Gastrointestinal Function","Complicated Appendicitis","RECRUITING","2026-06-20",{"date":32,"type":33},"2026-06-25","ACTUAL",{"date":35,"type":20},"2026-06-21",{"date":37,"type":20},"2029-06-30",{"name":39,"class":40},"Nanchong Central Hospital","OTHER_GOV",1,{"id":43,"slug":44,"hasResults":11,"nctId":45,"briefTitle":46,"officialTitle":47,"acronym":48,"eligibilityCriteria":49,"healthyVolunteers":11,"sex":16,"minAge":50,"maxAge":51,"enrollmentInfo":52,"targetDuration":4,"studyType":21,"phases":54,"briefSummary":56,"conditions":57,"keywords":60,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":62,"lastUpdatePostDateStruct":63,"startDateStruct":65,"completionDateStruct":67,"leadSponsor":69,"locationsCount":72},"100497733","phase-4-fast-track-therapeutic-model-in-acute-complicated-appendicitis-in-pediatrics-100497733","NCT05761080","Fast Track Therapeutic Model in Acute Complicated Appendicitis in Pediatrics","Evaluation of a Therapeutic Strategy to Shorten Hospital Stay in Complicated Pediatric Appendicitis: A Randomized, Parallel, Multicenter, Open-Label Clinical Trial","FTAA","Inclusion criteria:\n\n* Ages 2 to 17 years. Intraoperative diagnosis of complicated appendicitis. Laparoscopic appendectomy. Agreement to participate in the study with signed informed consent.\n\nExclusion criteria:\n\n* Peritonitis with sepsis criteria. Catarrhal or phlegmonous appendicitis. History of cystic fibrosis, Crohn's disease, or transplant that may interfere with the usual postoperative course of laparoscopic appendectomy.\n\nContraindication to the administration of amoxicillin-clavulanic acid. Refusal to participate in the study by parents\u002Flegal guardians.","2 Years","17 Years",{"count":53,"type":20},772,[55],"PHASE4","To evaluate whether a postoperative therapeutic strategy, Fast Track, aimed at shortening hospital stay in pediatric patients undergoing laparoscopic appendectomy for complicated acute appendicitis, yields outcomes that are not inferior to the standard therapeutic model in terms of the combined variable of adverse events within 30 days postoperatively (including postoperative abdominal abscess, peritonitis, surgical wound complications, reintervention, sepsis, or death).",[58,28,59],"Laparoscopic Appendectomy","Periappendicular Abscess",[61],"Complicated appendicitis","2026-03-19",{"date":64,"type":33},"2026-03-20",{"date":66,"type":33},"2021-04-22",{"date":68,"type":20},"2027-12",{"name":70,"class":71},"Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau","OTHER",7,{"id":74,"slug":75,"hasResults":11,"nctId":76,"briefTitle":77,"officialTitle":78,"acronym":79,"eligibilityCriteria":80,"healthyVolunteers":11,"sex":16,"minAge":81,"maxAge":4,"enrollmentInfo":82,"targetDuration":4,"studyType":21,"phases":84,"briefSummary":86,"conditions":87,"keywords":4,"overallStatus":89,"whyStopped":4,"lastUpdateSubmitDate":90,"lastUpdatePostDateStruct":91,"startDateStruct":93,"completionDateStruct":95,"leadSponsor":97,"locationsCount":4},"100580723","phase-3-laparoscopic-antibiotic-lavage-to-prevent-intra-abdominal-abscess-formation-in-complicated-appendicitis-100580723","NCT06841003","Laparoscopic Antibiotic Lavage to Prevent Intra-abdominal Abscess Formation in Complicated Appendicitis","Laparoscopic Antibiotic Lavage to Prevent Intra-abdominal Abscess Formation in Complicated Appendicitis (ALPACA), a Multicenter Single-blinded RCT.","ALPACA","Inclusion Criteria:\n\n* All patients ≥ 8 years with a preoperative diagnosis of acute appendicitis either with or without clinical or radiological suspicion of CA undergoing a laparoscopic appendectomy for intra-operative confirmed CA that can provide a signed written consent form.\n\nExclusion Criteria:\n\n* Age under 8 years;\n* Not able to give informed consent (language barrier, legally incapable)\n* Any contraindication for the use of the study medication:\n\n  * Hypersensitivity to clindamycin or to any of the excipients benzyl alcohol, sodium edetate, water, or to lincomycin;\n  * Hypersensitivity to gentamicin or to sodium metabisulfite: particularly in asthmatic patients, this may trigger bronchospasms and anaphylactic shock or to any of the excipients: disodium edetate, sodium hydroxide, sodium metabisulfite (E223), water for injections;\n* Severe sepsis defined as sepsis-induced tissue hypoperfusion or organ dysfunction that includes any of the following thought to be caused by the infection:\n\n  * Sepsis-induced hypotension\n  * Lactate above upper limits laboratory normal\n  * Urine output \\\u003C0.5 mL\u002Fkg\u002Fh for more than 2h despite adequate fluid resuscitation\n  * Acute lung injury with PaO2\u002FFiO2 \\\u003C250 in the absence of pneumonia as infection source\n  * Acute lung injury with PaO2\u002FFiO2 \\\u003C200 in the presence of pneumonia as infection source\n  * Creatinine \\>2.0 mg\u002FdL (176.8 μmol\u002FL)\n  * Bilirubin \\>2mg\u002FdL (34.2 μmol\u002FL)\n  * Platelet count \\\u003C 100,000 μL\n  * Coagulopathy (international normalized ratio (INR) \\> 1.5);\n* ASA IV score;\n* Known malignancy;\n* Renal dysfunction (i.e. eGFR ≤ 60);\n* Immunocompromised patients (i.e. hematological malignancies, HIV\u002FAIDS, bone marrow transplantation, splenectomy, genetic disorders such as severe combined immunodeficiency, chemotherapy, dialysis, solid organ transplant, and immunosuppressant use (such as corticosteroids in patients with rheumatoid arthritis));\n* Pregnancy;\n* Known allergies to either gentamicin or clindamycin;\n* Known colonization of bacteria resistant to either gentamicin or clindamycin;","8 Years",{"count":83,"type":20},752,[85],"PHASE3","Appendicitis is one of the most common causes of acute surgical admission. Presently, two types of appendicitis are distinguished: complicated and uncomplicated (phlegmonous). Complicated appendicitis (CA) is defined as gangrenous and\u002For perforated appendicitis and\u002For appendicitis with an intra-abdominal or pelvic abscess. Laparoscopic appendectomy has become the preferential mode of surgical treatment. However, development of an intra-abdominal abscess (IAA) remains an important and clinically relevant complication following appendectomy, especially in complicated appendicitis. Although patients with complicated appendicitis receive postoperative intravenous antibiotics, the incidence of IAA remains considerable. The reported incidence of IAA in children and adults with CA is 7.9% - 24%. We recently reported an IAA rate of 12.3% after laparoscopic appendectomy for CA in our own institution. Patients with IAA are readmitted and treated with either antibiotics, image-guided percutaneous drainage, surgical reintervention, or a combination of these treatments. Furthermore, IAA represents a considerable burden for the healthcare system with high readmission rates and reinterventions, prolonged hospital stay, and therefore increased medical costs. Intra operative techniques aiming at more effective infection source control represent a clinically relevant area of investigation. Laparoscopic antibiotic lavage represents a promising concept in order to reduce intra-abdominal abscess formation. Antibiotic lavage is mainly known for the treatment of peritoneal dialysis associated peritonitis. Several studies show promising results of antibiotic peritoneal lavage on the incidence of surgical site infections (SSIs) including IAA in patients with CA. However, these studies were retrospective or conducted in a small number of patients who underwent an open appendectomy while high quality randomized controlled trials have not been performed yet.\n\nThe aim of the ALPACA study is to evaluate the effect of laparoscopic antibiotic peritoneal lavage with gentamicin \u002F clindamycin for 3 minutes after appendectomy on the incidence of IAA in patients with CA.",[28,88],"Intra-Abdominal Abscess","NOT_YET_RECRUITING","2025-02-18",{"date":92,"type":33},"2025-02-21",{"date":94,"type":20},"2025-02",{"date":96,"type":20},"2027-05",{"name":98,"class":71},"Spaarne Gasthuis"]